Summary

Bioheart, Inc. (Bioheart) is a biotechnology company. It focuses solely on providing cell technologies that aid in the treatment of cardiovascular and related diseases. Its product candidates include Myocell, Myocell SDF-1, Myocath, and Adipocell. Myocell is a muscle stem cell theraphy that intends to improve the cardiac function of a damaged heart after a severe heart attack Myocell SDF-1 is an improved version of Myocell. Here the myoblast cells to be injected are gene-modified prior to injection by an adenovirus vector so that they will release extra quantities of stromal derived factor – 1 or SDF-1 protein. Myocath is a disposable needle injection catheter that is used to deliver biologic solutions to a targeted treatment sitewithin the inner wall of the heart. Adipocell is to treat patients with chronic ischemic cardiomyopathy, The company has recently applied to the FDA to begin trials with Adipocell. The company is currently conducting clinical trials for all of its product candidates in Europe and the US. Bioheart is headquartered in Florida, the US.

Bioheart, Inc. (BHRT) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Bioheart, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Bioheart, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 7
Bioheart, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Bioheart, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 9
Bioheart, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 10
Bioheart, Inc., Medical Equipment, Deal Details 11
Partnerships 11
Bioheart Extends Licensing Agreement With Airspeed Equity 11
Bioheart Enters Into Licensing Agreement With Airspeed Equity 12
Bioheart Signs Licensing Agreement With Monebo 13
Bioheart Enters Into Licensing Agreement With Ageless Regenerative Institute For Adipose Cell Technology 14
Equity Offering 15
Bioheart to Raise USD3 Million in Private Placement of Shares 15
Bioheart Completes Private Placement Of Shares For US$3 Million 16
Bioheart Completes Private Placement Of Shares 17
Bioheart Announces Private Placement Of Shares For US$2 Million 18
Bioheart Receives Equity Investment From AnC Bio Holdings 19
Bioheart Completes Private Placement Of US$2.9 Million 20
Bioheart Announces Private Placement Of US$7 Million 21
BioHeart Completes Private Placement Of US$1.8 Million 22
BioHeart Completes IPO Of US$5.78 Million 23
Debt Offering 25
Bioheart Raises USD3 Million in Private Placement of Notes 25
Bioheart, Inc. - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Strategy And Business Planning 29
Sep 24, 2014: Bioheart Announces Successful Grand Opening of Facility in South Africa 29
Sep 16, 2014: Bioheart Announces Grand Opening of Facility in South Africa 30
Nov 25, 2013: Bioheart Announces New Clinical Site in Mexico 31
Nov 04, 2013: Bioheart Announces Agreement With Global Stem Cell Group to Provide Bioheart Therapies and Training 32
Financial Announcements 33
Aug 07, 2014: Bioheart Releases Q2 Financial Information Showing Growth 33
May 15, 2014: Bioheart Reports Significant Revenue Increases 34
May 09, 2013: Bioheart Reports Q1 2013 Results 35
Mar 29, 2013: Bioheart Reports 2012 Results 36
Corporate Communications 37
Dec 19, 2013: Bioheart Reports Update on CEO 37
Nov 18, 2013: Bioheart's President/CEO Mike Tomas Named Chair of the eMerge Innovate Advisory Board of eMerge Americas 38
Sep 23, 2013: Bioheart Boosts Team with Regulatory, Finance and Administrative Expertise Three New Key Positions Added 39
Aug 28, 2013: Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc. 40
Government and Public Interest 41
Dec 31, 2013: Bioheart to Present at Vail Symposium's Winter Program on Cell Therapy 41
Product News 42
Jul 02, 2013: Bioheart Announces Phase III MIRROR Trial for MyoCell Initiated 42
Clinical Trials 43
Jul 02, 2013: Bioheart Announces Phase III MIRROR Trial for MyoCell Initiated 43
Other Significant Developments 44
Feb 24, 2014: Bioheart Reports Positive Update on CEO Mike Tomas 44
Dec 02, 2013: Bioheart Announces Agreement With StemMD to Provide Bioheart Therapies to Its Network 45
Oct 25, 2013: Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East 46
Oct 16, 2013: Bioheart Announces Contract With African-Middle East Medical to Begin Distributing Stem Cell Products in Uganda 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Bioheart, Inc., Medical Equipment, Key Facts, 2013 1
Bioheart, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Bioheart, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 7
Bioheart, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Bioheart, Inc., Deals By Market, 2008 to YTD 2014 9
Bioheart, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 10
Bioheart Extends Licensing Agreement With Airspeed Equity 11
Bioheart Enters Into Licensing Agreement With Airspeed Equity 12
Bioheart Signs Licensing Agreement With Monebo 13
Bioheart Enters Into Licensing Agreement With Ageless Regenerative Institute For Adipose Cell Technology 14
Bioheart to Raise USD3 Million in Private Placement of Shares 15
Bioheart Completes Private Placement Of Shares For US$3 Million 16
Bioheart Completes Private Placement Of Shares 17
Bioheart Announces Private Placement Of Shares For US$2 Million 18
Bioheart Receives Equity Investment From AnC Bio Holdings 19
Bioheart Completes Private Placement Of US$2.9 Million 20
Bioheart Announces Private Placement Of US$7 Million 21
BioHeart Completes Private Placement Of US$1.8 Million 22
BioHeart Completes IPO Of US$5.78 Million 23
Bioheart Raises USD3 Million in Private Placement of Notes 25
Bioheart, Inc., Key Competitors 26
Bioheart, Inc., Key Employees 27

List of Figures
Bioheart, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Bioheart, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 7
Bioheart, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Bioheart, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 9

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.